“The Minneapolis neighborhood where the University of Minnesota is located has seen a notable crime drop after increasing its police presence.”

“The University of Minnesota is conducting the nation's first randomized trial of a controversial anti-parasite drug that has a fervent U.S. following and is being used on the black market against COVID-19 across the globe.”

Now, will they do a good trial or give it to the wrong patients? There are three primary outcomes. Measure blood oxygen (<93%), did you have to use the emergency room, and PASC assessment questionnaire. Secondary outcome measures seem to be measured very late and do not start until 14-days.

Also, the laboratory outcomes are only for the first 70-patients. So those statistics will be very weak and not tell you much. And further notice that these 70 patients probably have their labs complete and with Ivermectin added so late, we doubt that any ivermectin patients will have any of the labs.  We think this study design is extremely poor and maybe that is the way they want it.  Prove us wrong U of M.

See the first comment to find the clinical trial.

The is from Michael Osterholm's Group at the University of Minnesota.  "A new study from China showed that antibodies faded quickly in both asymptomatic and symptomatic COVID-19 patients during convalescence, raising questions about whether the illness leads to any lasting immunity to the virus afterward.”

This raises a question of whether there may be a lasting immunity and that includes herd immunity.

"Three weeks ago on these pages, my colleague V.V. Chari and I asserted that a limited mass quarantine period would make sense only if we used the time it bought us to radically change the facts on the ground regarding our ability to test and trace. Thankfully, it appears our state has indeed used this time to increase its ability to test, trace, and isolate."

"In this episode, Dr. Osterholm and host Chris Dall discuss whether the US is nearing an apex in COVID-19 cases, what it may look like to “reopen” the country, a reality check regarding widespread testing, and what to make of the constant stream of new information and research findings."

This is a worthwhile 38-minute audio. Highly Recommended.